Resolution of intraventricular hemorrhage varies by ventricular region and dose of intraventricular thrombolytic: the CLEAR IVH Program

摘要

Background and PurposeThe CLEAR-IVH program is assessing the efficacy of intraventricular recombinant tissue Plasminogen Activator (rtPA) for spontaneous intraventricular hemorrhage (IVH). This subanalysis assesses the effect of dose of rtPA by region on clearance of IVH.